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PURPOSE: Over the past 21 years, we have performed more than 200 subtotal splenectomies, in which the upper splenic pole
vascularized only by the gastrosplenic pole vascularized only by the gastrosplenic vessels is preserved, to treat different pathologic
conditions. A meticulous follow-up of the postoperative results of this procedure is of fundamental importance.
METHODS: All patients undergoing subtotal splenectomy were invited to be reviewed. A total of 86 patients who had undergone
surgery 1 to 20 years ago were gathered; the surgical procedure was performed for one of the following conditions: portal hypertension
due to schistosomiasis (n = 43), trauma (n = 31), Gaucher’s disease (n = 4), myeloid hepatosplenomegaly due to myelofibrosis (n
= 3), splenomegalic retarded growth and sexual development (n = 2), severe pain due to splenic ischemia (n = 2) and pancreatic
cystadenoma (n = 1). Patients underwent a hematologic exam, an immunologic assessment, abdominal ultrasonography, computed
tomography, scintigraphy and endoscopy.
RESULTS: Increased white blood cell count and platelets were the only hematological abnormalities. No immunologic deficit
was found. Esophageal varices were still present in patients who underwent surgery because of portal hyperension although
without rebleeding. The ultrasound, tomography and scintigraphy exams confirmed the presence of functional splenic remnants
without significant size alteration.
CONCLUSIONS: Subtotal splenectomy seems to be a safe procedure that can be useful in treating conditions involving the
spleen. The functions of the splenic remnants are preserved during long periods of time.
KEYWORDS: Partial splenectomy. Subtotal splenectomy. Spleen. Splenic preservation. Postoperative.
Our studies relating to subtotal splenectomy preserving
the upper pole vascularized by the splenogastric vessels be-
gan in 1979. After five years of experimental investigations
in mice, rats, rabbits, cats, dogs and pigs, we were author-
ized by our Institution to operate on patients with portal
hypertension due to schistosomiasis and previous variceal
bleeding, and later extending to other diseases.1-9
In an attempt to preserve the splenic function, we main-
tained the upper splenic pole (subtotal splenectomy). Pre-
viously we had combined this procedure with a splenorenal
shunt.10-13 In the presence of hepatic failure, cardiopulmo-
nary congestive dysfunction or encephalopathy, especially
in patients over 40 years of age, we combine the subtotal
splenectomy with external portal variceal disconnection and
suture gastric and esophageal varices, through an anterior
gastrotomy.14 We find this option better than a portal sys-
temic shunt.
Subtotal splenectomy was also performed in patients
with Gaucher’s disease in which giant splenomegaly caused
abdominal discomfort, respiratory distress and walking dif-
ficulties.15,16 A total splenectomy in this disease frequently
causes liver enlargement and bone fractures due to depo-
sition of glucocerebroside.17-20 Lethal infection is another
complication that may follow total splenectomy.20 To avoid
this complication, partial splenectomy, preserving the
splenic pedicle has been proposed.17,18 However, several re-
ports have described splenic remnant enlargement, leading
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to recurrent hypersplenism. 19,20 The maintenance of the
upper pole vascularized by the splenogastric vessels poten-
tially avoids some of those complications and does not re-
sult in spleen enlargement. 15,21,22
Myeloid hepatosplenomegaly due to myelofibrosis is an-
other disease that may induce an extraordinary enlargement
of the spleen. 23 The giant spleen leads not only to the same
discomfort similar to that described in Gaucher’s disease, but
also to severe hematological complications. 24-26 Even though
total splenectomy may be helpful in myeloid hepatosplenom-
egaly this procedure results in great morbidity and mortal-
ity. 23-28 Postoperative massive liver enlargement and rupture
due to myeloid hepatomegaly, infections and bleeding are
the most frequent complications of total splenectomy. 24,26-30
Splenic artery ligation and partial splenectomy with preser-
vation of the splenic pedicle are only palliative, since symp-
toms and splenic enlargement usually recur. 29-33 Preserva-
tion of the uppermost part of the spleen vascularized only
by the splenogastric vessels maintains splenic function with-
out enlargement of the organ. 21,34
In trauma, the spleen is almost always normal and there
is no reason to remove this important organ. The multiple
complications of the asplenic condition, including severe
sepsis and precocious death are well established in the lit-
erature. 35,36 In order to prevent such adverse events, non-
operative management and surgical procedures that pre-
serve the spleen are routinely performed at most of ad-
vanced emergency services. 37,38 Injuries to the splenic pedi-
cle have challenged both non operative management and
conservative operations. In these cases, we have success-
fully performed subtotal splenectomy, preserving the up-
per splenic pole supplied only by the splenogastric vessels.
Traditionally, distal pancreatectomy has included total
splenectomy. 40,41 Preservation of the spleen after ligation
of its pedicle and maintenance of its main branches have
been proposed in the literature. 40-44 However, when it is
not possible to preserve the splenic pedicle or its major
branches, the surgeon may still preserve the upper pole sup-
plied by the splenogastric vessels. 45
According to published reports, the presence of
splenomegaly in children and teenagers leads to retarded
of growth and late sexual development, and therefore total
splenectomy is frequently indicated. 46 However, in our ex-
perience, subtotal splenectomy is sufficient to induce nor-
mal growth. 47 Patients who were operated by us using this
procedure reached normal somatic and sexual development
in less than two years.
Another indication for total splenectomy is leukemia and
lymphomas that are hardly controlled by chemotherapeutic
drugs. Even in these cases, subtotal splenectomy is a better
option due to the maintenance of the splenic defense capa-
bilities without the adversities of splenomegaly.48
Vascular thrombosis and splenic malformations may pro-
voke severe pain that does not respond to regular analgesic
drugs. In these cases, removal of the spleen is indicated. To
avoid the complications of the asplenic condition, we have
performed laparoscopic subtotal splenectomy. This operation
preserves the upper splenic pole with its proper vessels that
prevent the effects of vascular pedicle thrombosis.49,50
The present paper describes the late follow up of 86 pa-
tients that are a subpopulation of the more than 200 pa-
tients who underwent subtotal splenectomy during the past
20 years at our institution.
METHODS
We assessed 86 patients who had undergone subtotal
splenectomy (Figure 1) from 1 to 20 years previously for
one of the following conditions: portal hypertension due
to schistosomiasis with previous variceal bleedings (n = 43),
trauma (n = 31) Gaucher’s disease (n = 4), myeloid hepat-
osplenomegaly due to myelofibrosis (n = 3), splenomegalic
retarded growth and sexual development (n = 2), severe
pain caused by splenic ischemia (n = 2) and cystadenoma
of the pancreatic tail (n = 1). Other patients who had un-
dergone the procedure refused to undergo the exams or did
not return and were excluded from the present investiga-
tion. There were 55 men and 31 women in this study group.
Their ages at the time of this study ranged from 17 to 81
(44.4 ± 18.8) years at the time of the present study.
In addition to answering questions related to their dis-
ease, operation and postoperative period the patients under-
went complete physical examination. Complementary exams
included laboratory hematological and immunological (IgM,
IgA, IgG, and active B and T lymphocytes) evaluation, up-
per GI endoscopy, abdominal ultrasonography, abdominal CT
scan and splenic scintigraphy with 99mTc sulfur colloid.
Figure 1 - Surgical aspect of subtotal splenectomy performed in a patient
with portal hypertension. Observe the splenogastric vessels (arrow)
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RESULTS
All patients were satisfied with the results of the op-
eration. They had no severe complication in the postopera-
tive period. Episodes of fever (higher than 37.5 oC) were
confirmed by 34 patients, even in the late postoperative
period. These episodes were not related to signs of infec-
tion. Two patients were diagnosed with pneumonia in the
postoperative period: one had been treated for portal hy-
pertension and the other for myeloid hepatosplenomegaly.
Both were successfully treated with antibiotics.
At physical examination following surgery, discrete (n
= 8) or moderate (n = 2) ascites was found in 10 patients
with portal hypertension who underwent external portal
variceal disconnection. There was no evidence of hepatic
or renal disturbances among these patients.
Six patients had supraumbilical median incisional hernias.
Hepatomegaly at the level of the right rib frame was
found during physical examination of patients with myeloid
hepatomegaly. Patients with Gaucher’s disease had a pal-
pable liver at 3 to 5 cm below the rib cage.
The hematological exam revealed a red cell count rang-
ing from 4.0 to 5.6 x 106 / µl. The white cell count ranged
between 3400 and 47000 / µl. Higher values were observed
in patients with myelofibrosis. None of these patients had
septic manifestations. In the preoperative period, the white
cell count ranged from 1100 to 9400 / µl, with lower values
in patients with portal hypertension. Howell-Jolly bodies,
characteristic of asplenia, were not found in this series.
Platelets levels ranged from 135 x 103 to 430 x 103 / µl
except for two patients, one with portal hypertension (2055
x 106) and the other with myeloid hepatosplenomegaly
(2142 x 106). Neither patient presented signs of
coagulopathy in the postoperative period. Before the op-
eration, the number of platelets ranged between 18 and 191
x 103 / µl, with not clinical abnormalities.
Postoperative prothrombin times were 64% to 100 % of
reference values. However, in the preoperative period, the pro-
thrombin time in patients with portal hypertension were 41
% to 79 % of reference time without clinical manifestations.
The immunological pattern showed normal level of
immunoglobulins in all patients. IgM ranged between 82
and 235 mg/100 ml, IgA from 141 to 604 mg/100 ml, and
IgG from 1000 to 2314 mg/100 ml. The levels of
lymphocytes were normal in all patients. Active B
lymphocytes levels ranged from 11 to 19 / mm3, and T
lymphocytes levels from 23 to 52 / mm3.
Endoscopy revealed esophageal varices in 33 patients and
gastric varices in 12 patients who had undergone the treat-
ment for portal hypertension. These varices were of smaller
than those found in the preoperative period. No signs sug-
gesting bleeding risk were found in any of these patients.
The ultrasound examination showed splenic remnant
ranging from 2.9 to 18.1 centimeters in 30 patients. The por-
tal vein revealed thrombosis of the left branch in 10 patients,
with no clinical manifestations. CT scans showed the splenic
upper pole stump supplied by the splenogastric vessels (Fig-
ure 2). Scintigraphic images of the splenic remnants were
positive in 54 cases (Figure 3). Twelve of the patients did
not present for the splenic scintigraphic image and twenty
patients did not receive authorization for this exam.
DISCUSSION
All patients who underwent subtotal splenectomy are
registered in our hospital, but unfortunately we could not
contact more than 40 % of them. This difficulty is very
common in Brazil because of widespread population mi-
gration. On the other hand, when the patients develop com-
plication following the surgical procedure, they do return
to the hospital of origin.
The outcome for patients who underwent subtotal
splenectomy in the present study was favorable in various
Figure 2 - Tomographic image of splenic remnant during the late
postoperative periods following subtotal splenectomy for splenic ischemia.
Observe the splenogastric vessels (arrow)
Figure 3 - Scintigraphic images (using 99mTc sulfur colloid) of a splenic
remnant (arrow) after subtotal splenectomy for portal hypertension
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aspects. Previously, we verified that postsplenectomy in-
fection is very rare in adults undergoing surgery for portal
hypertension due to schistosomiasis 13,51 However some pa-
tients presented with fever episodes without immune defi-
ciency. 13 Even though postsplenectomy fever is frequently
reported in the literature, the exact mechanism is not com-
pletely understood. 52,53 Some of our patients presented such
episodes of fever until the late postoperative period. Epi-
sodes of fever were not considered to be a problem for the
patients in the present study. Pneumonia was the only se-
vere postoperative infection and had a benign course.
Ascites is a frequent finding in the early postoperative
period of patients with portal hypertension due to schisto-
somiasis. 13 Some patients may persist with this complica-
tion for longer periods of time. Control with diuretics is
the therapeutic regimen of choice and was employed with
our patients; this complication did not represent a major
problem.
In this study we describe incisional hernias due to fail-
ure of the supraumbilical median incision closure. The care
not to damage the veins of the hepatic round ligament
played an important role in the development of this com-
plication. The development of these hernias led us to
change the operative approach to a left medial paramedian
incision. During the last 14 years, using this approach, we
have not had major incisional complications.
All patients with myeloid hepatosplenomegaly had en-
largement of the liver during the early postoperative period.
However, after 6 months, this organ reduced its size. Report-
edly, the enlargement of the liver is one of the most severe
complications after total splenectomy in patients with this
disorder. 27-30 Lethal hemorrhages and an extreme discom-
fort may occur in such circumstances. We did not find re-
ports in the literature of a significant hepatic reduction. In
our patients, livers, that increased in size by 12 to 14
centimeters immediately after the subtotal splenectomy are
now palpable at the level of rib cage. We believe that par-
tial preservation of the spleen may be involved in this ob-
servation, therefore the finding should be better evaluated.
Leukocytosis and thrombocytosis of the splenectomized
patients have not been well explained in the literature. The
absence of clinical manifestations indicates that this is a
benign condition that should not be called hypersplenism,
which refers to a severe disorder of the spleen. 54
A frequent complication for patients with Gaucher’s dis-
ease undergoing total splenectomy is severe bone pain and
frequent fractures. 16,19,20 Hepatic enlargement with functional
compromise may also occur. Our patients presented no bone
complaints and their liver enlargement was moderate.
In portal hypertension due to schistosomiasis, the pro-
thrombin time is almost always under 70 % of the refer-
ence time. This is not well understood, but it does not mean
coagulopathy. 54 After subtotal splenectomy, all patients in-
creased prothrombin time, in presence of remnant of splenic
tissue.
Esophageal and gastric varices of patients with portal
hypertension rarely disappear after surgical treatment. It is
of the utmost importance to relieve internal variceal pres-
sure. The complete absence of late postoperative bleedings
confirms the efficacy of our procedures. Partial splenectomy
with preservation of the splenic pedicle for the treatment
of portal hypertension due to schistosomiasis has been pub-
lished previously. 55,56 However, the reported results were
not as good as those obtained in our study, probably due
to the adverse effects induced by the maintenance of the
splenic vascular pedicle.
Partial splenectomy with preservation of the splenic pedi-
cle, usually results in splenic remnant enlargement provok-
ing abdominal discomfort especially in patients with portal
hypertension, Gaucher’s disease or myeloid hepatosplenom-
egaly. 20,31,32,55 This symptoms by itself was an indication for
surgery in the present study. The splenogastric vessels main-
tain the vitality of the upper pole. However, these vessels
are incapable of inducing enlargement of the organ or blood
supply to an enlarged spleen. 49 Nevertheless, the splenic
stump maintains the functions of the organ.
Clinical, laboratory and scintigraphic studies showed
that the function of all splenic remnants. Further improve-
ment of splenic function along with time was observed both
experimentally and clinically in the present investigation.
The absence of splenic images in some scintigraphies may
be explained by failures of the method, since hematologic
and immunologic exams did not show signs of asplenic
process. Reportedly, inadequate tomographic and scinti-
graphic images may occur in 5 % to 30 % of these tests.
57-59
 The factors that produce this failure in imaging have
not yet been established. 60
In conclusion, the 20 years of follow-up of patients un-
dergoing subtotal splenectomy have shown that this pro-
cedure should be considered for the treatment of trauma,
portal hypertension, myeloid hepatosplenomegaly, Gau-
cher’s disease splenomegalic retarded growth and sexual
development due to splenomegaly, severe pain due to
splenic ischemia, chronic leukemia, lymphomas and sur-
gical disorders of the distal part of the pancreas. This pro-
cedure may be performed by laparotomy or laparoscopy
and seems to be a safe to treat conditions involving the
spleen. The functions of the splenic remnants are preserved
during long periods of time. Further studies with larger
number of cases should be performed to further evaluate
this therapeutic alternative.
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RESUMO
Petroianu A, Resende V, Silva RG da. Acompanhamento
pós-operatório tardio de pacientes submetidos a esplenec-
tomia subtotal. Clinics. 2005;60(6):473-8.
OBJETIVO: Durante 21 anos, realizamos mais de 200
esplenectomias subtotais para tratar diferentes condições
patológicas. É fundamental conhecer os resultados pós-ope-
ratórios desse procedimento.
MÉTODO: Todos os pacientes submetidos a esplenectomia
subtotal foram convidados para serem submetidos a revi-
são. Pudemos reunir 86 pacientes operados em um perío-
do de um a vinte anos por hipertensão porta esquistos-
somática com sangramento prévio pelas varizes (n = 43),
trauma (n = 31), doença de Gaucher (n = 4), hepato-
esplenomegalia mielóide devido a mielofibrose (n = 3), re-
tardo de desenvolvimento somático e sexual esplenome-
gálico (n = 2), dor intensa por isquemia esplênica (n = 2)
e cistoadenoma corpocaudal pancreático (n = 1). Os paci-
entes foram submetidos a exame hematológico, avaliação
imunológica, ultra-som, tomografia computadorizada,
cintilografia e endoscopia digestiva alta.
RESULTADOS: Aumento do número de leucócitos e
plaquetas foram a única alteração hematológica encontra-
da. Não foram constatados distúrbios imunológicos. Vari-
zes esofágicas ainda estavam presentes em pacientes ope-
rados de hipertensão porta, porém sem ressangramento. O
ultra-som, a tomografia computadorizada e a cintilografia
confirmaram a presença do remanescente esplênico
funcionante, sem mudanças em seu tamanho.
CONCLUSÃO: A esplenectomia subtotal parece ser um
procedimento seguro e pode seu útil para tratar condições
nas quais o baço estiver envolvido.
PALAVRAS-CHAVE: Esplenectomia parcial. Esplenec-
tomia subtotal. Baço. Conservação esplênica. Pós-ope-
ratório.
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